Literature DB >> 12858555

A mouse model of congenital heart disease: cardiac arrhythmias and atrial septal defect caused by haploinsufficiency of the cardiac transcription factor Csx/Nkx2.5.

M Tanaka1, C I Berul, M Ishii, P Y Jay, H Wakimoto, P Douglas, N Yamasaki, T Kawamoto, J Gehrmann, C T Maguire, M Schinke, C E Seidman, J G Seidman, Y Kurachi, S Izumo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12858555     DOI： 10.1101/sqb.2002.67.317

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN： 0091-7451


× No keyword cloud information.
  24 in total

1.  Ablation of Nkx2-5 at mid-embryonic stage results in premature lethality and cardiac malformation.

Authors:  Ryota Terada; Sonisha Warren; Jonathan T Lu; Kenneth R Chien; Andy Wessels; Hideko Kasahara
Journal:  Cardiovasc Res       Date:  2011-02-01       Impact factor: 10.787

2.  Axenfeld-Rieger syndrome-associated mutants of the transcription factor FOXC1 abnormally regulate NKX2-5 in model zebrafish embryos.

Authors:  Qinxin Zhang; Dong Liang; Yunyun Yue; Luqingqing He; Nan Li; Dongya Jiang; Ping Hu; Qingshun Zhao
Journal:  J Biol Chem       Date:  2020-07-06       Impact factor: 5.157

3.  A mouse model of human congenital heart disease: high incidence of diverse cardiac anomalies and ventricular noncompaction produced by heterozygous Nkx2-5 homeodomain missense mutation.

Authors:  Hassan Ashraf; Lagnajeet Pradhan; Eileen I Chang; Ryota Terada; Nicole J Ryan; Laura E Briggs; Rajib Chowdhury; Miguel A Zárate; Yukiko Sugi; Hyun-Joo Nam; D Woodrow Benson; Robert H Anderson; Hideko Kasahara
Journal:  Circ Cardiovasc Genet       Date:  2014-07-15

4.  Impaired mesenchymal cell function in Gata4 mutant mice leads to diaphragmatic hernias and primary lung defects.

Authors:  Patrick Y Jay; Malgorzata Bielinska; Jonathan M Erlich; Susanna Mannisto; William T Pu; Markku Heikinheimo; David B Wilson
Journal:  Dev Biol       Date:  2006-10-05       Impact factor: 3.582

5.  Heterogeneity of genetic modifiers ensures normal cardiac development.

Authors:  Julia B Winston; Jonathan M Erlich; Courtney A Green; Ashley Aluko; Kristine A Kaiser; Mai Takematsu; Robert S Barlow; Ashish O Sureka; Martin J LaPage; Luc L Janss; Patrick Y Jay
Journal:  Circulation       Date:  2010-03-08       Impact factor: 29.690

Review 6.  Fates Aligned: Origins and Mechanisms of Ventricular Conduction System and Ventricular Wall Development.

Authors:  William R Goodyer; Sean M Wu
Journal:  Pediatr Cardiol       Date:  2018-03-28       Impact factor: 1.655

Review 7.  Genetic causes of human heart failure.

Authors:  Hiroyuki Morita; Jonathan Seidman; Christine E Seidman
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

8.  Nkx2-5 mutation causes anatomic hypoplasia of the cardiac conduction system.

Authors:  Patrick Y Jay; Brett S Harris; Colin T Maguire; Antje Buerger; Hiroko Wakimoto; Makoto Tanaka; Sabina Kupershmidt; Dan M Roden; Thomas M Schultheiss; Terrence X O'Brien; Robert G Gourdie; Charles I Berul; Seigo Izumo
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

9.  Genetic and environmental risk factors in congenital heart disease functionally converge in protein networks driving heart development.

Authors:  Kasper Lage; Steven C Greenway; Jill A Rosenfeld; Hiroko Wakimoto; Joshua M Gorham; Ayellet V Segrè; Amy E Roberts; Leslie B Smoot; William T Pu; Alexandre C Pereira; Sonia M Mesquita; Niels Tommerup; Søren Brunak; Blake C Ballif; Lisa G Shaffer; Patricia K Donahoe; Mark J Daly; Jonathan G Seidman; Christine E Seidman; Lars A Larsen
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-16       Impact factor: 11.205

10.  Slow progressive conduction and contraction defects in loss of Nkx2-5 mice after cardiomyocyte terminal differentiation.

Authors:  Morihiko Takeda; Laura E Briggs; Hiroko Wakimoto; Melissa H Marks; Sonisha A Warren; Jonathan T Lu; Ellen O Weinberg; Keith D Robertson; Kenneth R Chien; Hideko Kasahara
Journal:  Lab Invest       Date:  2009-06-22       Impact factor: 5.662
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.